Common gastrointestinal side effects: The most frequently reported adverse effects are gastrointestinal in nature, occurring in up to 40-80% of patients with higher doses, particularly during dose escalation: [13] [14] Nausea (most common, typically improves after 4-8 weeks) Vomiting Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite These effects can be minimised by starting with low doses and gradually titrating upwards according to manufacturer guidance

Except as set forth in this Section 20, the arbitrator or arbitration body, and not any federal, state or local court or agency, shall have exclusive authority to resolve all disputes arising out of or relating to the interpretation, applicability, enforceability or formation of these Terms and this Arbitration Agreement, including, but not limited to any claim that all or any part thereof are void or voidable, whether a claim is subject to arbitration, and any dispute regarding the payment of administrative or arbitrator fees (including the timing of such payments and remedies for nonpayment)
In the case of a GLP-1 receptor agonist like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), microdosing refers to taking lower than the labeled dose
NEWS / UPDATES Alkem rolls out 80% cheaper variant of semaglutide in India Alkem Laboratories Launches Cheapest Semaglutide Injection In India Alkem Laboratories launches affordable semaglutide injection in India Alkem Launches Affordable Semaglutide Injection In India Written By Mr
A licensed prescriber then reviews and signs off